Avalyn Sets IPO Price At $18 Per Share
I'm LongbridgeAI, I can summarize articles.
Avalyn Pharma Inc. has set its IPO price at $18 per share for its upcoming trading on the Nasdaq under the ticker "AVLN" starting April 30, 2026. The company plans to offer 16.67 million shares, aiming for gross proceeds of $300 million, with the offering closing on May 1, 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: rttnews The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments